A Member of the Cancer Information Network
top menu - left Physician Resource Center CancerConsultants Patients Home divider CancerConsultants.com Home divider Cancer Consultants Espanol
Advertisement

Pancreatic Cancer Information Center

Pancreatic Cancer Information Center  

A new or recurrent diagnosis of pancreatic cancer often results in fear and confusion for patients and their family members. Understanding treatment options, accessing new and innovative therapies through clinical trials, as well as understanding the role of supportive care and complementary and alternative medicine are essential. Cancer screening, genetic testing and prevention are equally relevant to all individuals, especially those related to someone diagnosed with cancer.

Pancreatic Cancer Management

Advertisement

Cancer Tips

Cancer Tips   Lifestyle and Environmental Factors Responsible for Many Cancer Deaths


double arrow More cancer tips...

Pancreatic Cancer News

Obesity Increases Pancreatic Cancer Risks (06/25/2009)
Overweight or obesity during early adulthood increases the risk of developing pancreatic cancer and is also linked with a younger age at diagnosis. Overweight or obesity later in life is linked with worse pancreatic cancer survival. These results were published in the Journal of the American Medical Association.

Healthy Lifestyle Lowers Risk of Pancreatic Cancer (05/13/2009)
According to the results of a study published in the Archives of Internal Medicine, individuals with the healthiest lifestyles cut their risk of pancreatic cancer by more than half.

Obesity Worsens Outcomes After Surgery for Pancreatic Cancer (03/30/2009)
According to the results of a study published in the Archives of Surgery, pancreatic caner patients with a body mass index (BMI) greater than 35 have a greater risk of recurrence and worse survival after surgery than patients with a lower BMI.

Blood Type Linked to Risk of Pancreatic Cancer (03/20/2009)
Individuals with A, AB, or B blood types may have a higher risk of developing pancreatic cancer, according to the results of a study published in the Journal of the National Cancer Institute.

Sutent® Provides Significant Benefit for Advanced Pancreatic Islet Cell Tumors: Clinical Trial Stopped Early (03/12/2009)
Sutent® (sunitinib malate) has been shown to significantly increase progression-free survival in patients with advanced pancreatic islet cell tumors, leading Pfizer Inc. to halt their Phase III trial early.

double arrow More Pancreatic Cancer Cancer News...

Additional Pancreatic Cancer Topics

  • Screening and Prevention
    Learn about techniques used in screening for cancer, as well as prevention and genetic testing.
  • Managing Side Effects
    Learn about common treatment-related side effects and strategies to manage and/or reduce them.
  • Personalized Member Center
    Register in our member center today to receive email notification of late breaking cancer news.
  • Clinical Trials
    Search our national database of clinical trials.
  • Coping with Cancer
    Read more about coping strategies for patients and caregivers.
  • Cancer Tips
    Read cancer patient tips written by patients and professionals, updated monthly.